
From Journey to Action: Using Longitudinal Patient-Level Insights to De-Risk and Accelerate Clinical Trials
Key Takeaways
- Understand why longitudinal patient-level insight across the complete journey enables more precise strategy, planning, and outcomes.
- Learn how longitudinal patient journeys translate into actionable recommendations and predictable operational outcomes across protocol optimization, feasibility planning, site/investigator selection, recruitment, patient cohorts/funnel, and site enablement.
In this interview, Skye Hodson, PhD, of Citeline, explains how longitudinal, patient-level insights across the full care journey are helping sponsors overcome enrollment delays, investigator scarcity, and protocol complexity—transforming strategy into execution-ready deliverables that optimize feasibility, site selection, and measurable recruitment outcomes.
Sponsored by Citeline
From Protocol to Patient: A New Blueprint for Success
This strategic playbook introduces a new, connected approach to feasibility, bridging the gap between protocol planning and patient delivery. Our holistic approach brings real-world data (RWD), proprietary Citeline data, and AI-powered intelligence into a single workflow. The result? Protocols that are not only scientifically sound but built for real-world success.
Gain insights on these elements of success — and more:
- A continuous, data-driven feedback loop
- A fully connected clinical trial planning workflow
- A combination of RWD longitudinal patient data and proprietary data assets
Access the full playbook




